Ashu Singhal
Overview
Ashu Singhal co-founded Benchling in 2012, aiming to accelerate life sciences research by providing a unified cloud-based platform for R&D data management. Under his leadership, Benchling has become a leading solution for biotech companies and academic labs, facilitating efficient collaboration and data analysis. As president, Singhal oversees the company's strategic direction and operations, focusing on expanding its global presence and enhancing product offerings. His vision has been instrumental in Benchling's growth, attracting significant investment and a diverse clientele. Singhal's commitment to innovation and excellence continues to drive Benchling's mission of transforming life sciences R&D through advanced technology and user-centric design.
Investment Focus
- Innovative life sciences companies
- Strong management teams
- Scalable business models
- Potential for significant impact in their respective fields
Portfolio Companies
Reach Ashu Singhal directly
Verified work email, phone and LinkedIn for the full team — one spreadsheet, one payment, yours to keep.
Unlock full contacts →Frequently asked questions about Ashu Singhal
What sectors does Ashu Singhal invest in?
Ashu Singhal invests in Healthcare, Energy, Consumer Goods, Agriculture, Food and Beverage and Pharmaceuticals, and is based in California, United States. Ashu Singhal is listed as a angel investor in the ConnectSafely investor database.
What stage does Ashu Singhal invest at?
Ashu Singhal backs companies at Seed, Early Stage, Series A, Series B, Growth and Late Stage, writing cheques of 1M - 50M.
Which regions does Ashu Singhal invest in?
Ashu Singhal invests across United States, United Kingdom, Canada, Germany, Japan and Australia.
What companies has Ashu Singhal invested in?
Ashu Singhal's portfolio includes Moderna, Vertex Pharmaceuticals, Merck, Sanofi and Corteva Agriscience.
Last updated · Source: ConnectSafely investor database